Niagen Bioscience Inc (NAGE)

Deferred Revenue

$329.00K

Quarterly · Period ending: · USD

NAGE logo

NAGE Deferred Revenue

Latest reported$329.00K
NAGE Quarterly Deferred Revenue ($0.00 → $329.00K)
High-resolution chart · PNG

NAGE deferred revenue history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Niagen Bioscience Inc Deferred Revenue — Quarterly (USD)
Period endingDeferred Revenue (USD)
329,000
0
0
0
303,000
207,000
611,000
184,000
156,000
227,000
195,000
189,000
166,000
148,000
157,000
158,000
173,000
141,000
161,000
175,000
210,000
231,000
278,000
228,000
250,000
238,000
169,000
261,000
293,000
363,000
275,000
155,000
185,000
202,000
314,000
321,119
503,850
399,010
389,010
277,615
262,852
339,600
272,002
236,828
229,184
393,352
234,435
225,917
263,270
389,024
546,044
659,645
336,824
314,468
310,267
257,004
169,612
219,802
199,693
299,687
159,267
252,530
112,427
88,652
71,455
109,987
162,135
186,541
0
0
34,260
0
0
0
0
0
0
0
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.